Figure 2
Figure 2. Loss of β-catenin prevents development of BM failure in Apc-deficient mice. (A) The number of white blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils (EO), basophils (BA), red blood cells (RBC), platelets (PLT), and hemoglobin (Hb) levels in PB from ApcΔ/Δ, ApcΔ/Δβ-cateninΔ/Δ, β-cateninΔ/Δ, or β-cateninfl/fl chimeric mice (CM) 7-13 days after last pI-pC injection (n = 5). (B) Representative histological analysis of hematoxylin and eosin–stained sternum from ApcΔ/Δ CM and ApcΔ/Δ β-cateninΔ/Δ CM 13 days after induction. (C) Numbers of total BM cells in ApcΔ/Δ, ApcΔ/Δβ-cateninΔ/Δ, β-cateninΔ/Δ, or β-cateninfl/fl CM 7-15 days after induction (mean ± standard deviation, n = 5-10). *P < .05; **P < .01; ***P < .001.

Loss of β-catenin prevents development of BM failure in Apc-deficient mice. (A) The number of white blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils (EO), basophils (BA), red blood cells (RBC), platelets (PLT), and hemoglobin (Hb) levels in PB from ApcΔ/Δ, ApcΔ/Δβ-cateninΔ/Δ, β-cateninΔ/Δ, or β-cateninfl/fl chimeric mice (CM) 7-13 days after last pI-pC injection (n = 5). (B) Representative histological analysis of hematoxylin and eosin–stained sternum from ApcΔ/Δ CM and ApcΔ/Δβ-cateninΔ/Δ CM 13 days after induction. (C) Numbers of total BM cells in ApcΔ/Δ, ApcΔ/Δβ-cateninΔ/Δ, β-cateninΔ/Δ, or β-cateninfl/fl CM 7-15 days after induction (mean ± standard deviation, n = 5-10). *P < .05; **P < .01; ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal